Meaningful Use Updates Stage 2 and 3. Julia Moore, Business Analyst SMC Partners, LLC July 8, 2015

Size: px
Start display at page:

Download "Meaningful Use Updates Stage 2 and 3. Julia Moore, Business Analyst SMC Partners, LLC July 8, 2015"

Transcription

1 Meaningful Use Updates Stage 2 and 3 Julia Moore, Business Analyst SMC Partners, LLC July 8, 2015

2 Stage 2 Requirements 2015 EPs beyond 1st year of MU must report on a full year of data EPs in 1 st year of demonstrating MU may use a 90-day reporting period 17 Core Objectives 3 of 6 Menu Objectives 9 CQMs Increased thresholds Some menu measures become core measures New measures

3 Core Measures 1. CPOE 2. erx 3. Demographics 4. Vitals 5. Smoking Status 6. Clinical Decision Support 7. View, Download, Transmit 8. Clinical Summaries 9. Protect Electronic PHI 10. Clinical Lab Test Results 11. Patient Reminders 12. Patient Lists 13. Education Resources 14. Medication Reconciliation 15. Summary of Care 16. Immunization Data 17. Secure Electronic Messaging

4 Computerized Provider Order Entry (CPOE) Measure: >60% of medication, >30% of laboratory, and >30% of radiology orders created by the EP during the reporting period are recorded using CPOE Exclusion: EP writes fewer than 100 medication, radiology, or laboratory orders during the reporting period *Added laboratory & radiology orders, medication orders threshold increased

5 E-Prescribing (erx) Measure: More than 50% of all permissible prescriptions written by the EP are compared to at least one drug formulary and transmitted electronically using CEHRT Exclusion: EP writes less than 100 prescriptions during the reporting period or EP does not have a pharmacy in their organization nor a pharmacy that can accept electronic prescriptions within 10 miles of the practice location *Threshold increased

6 Record Demographics Measure: >80% of all unique patients seen by the EP have demographics recorded as structured data. Demographics include preferred language, gender, race, ethnicity, date of birth Exclusions: None *Threshold increased

7 Record Vital Signs Measure: >80% of all unique patients seen by the EP have blood pressure (for patients age 3 and over only) and/or height and weight (for all ages) recorded as structured data. Exclusions: EP can be excluded from recording all three vital signs if they do not believe they are relevant to their scope of practice. EPs can be excluded from recording just blood pressure if they don t believe blood pressure is relevant, or just height and weight if they don t believe height and weights are relevant. EP s can be excluded from recording blood pressure if they see no patients age 3 or older. *Threshold increased, new exclusions

8 Record Smoking Status Measure: >80% of all unique patients 13 years old or older seen by the EP have smoking status recorded as structured data Exclusion: EP does not see any patients 13 years old or older *Threshold increased

9 Clinical Decision Support Measure: Implement 5 clinical decision support interventions related to 4 or more clinical quality measures, if applicable, at a relevant point in patient care for the entire reporting period and Enable the functionality for drug-drug and drug-allergy interaction checks for the entire reporting period. Exclusion: No exclusion for clinical decision support. EP can be excluded from drug interaction checks if they write <100 medication orders during the reporting period. *Increased to 5 rules & consolidated with drug interaction check measures

10 View online, Download and Transmit Measure: >50% of all unique patients are provided online access to their health information within 4 business days after the information is available to the EP and >5% of all unique patients view, download, or transmit to a third party their health information. Exclusions: EP is excluded if they do not order or create any of the required information, except for Patient name and Provider name and office contact information. EPs can also be excluded if practice is in an area with low broadband availability. *Must demonstrate use

11 Provide Clinical Summaries for Patients Measure: Clinical summaries provided to patients within one business day for >50% of office visits. Exclusion: EP does not conduct any office visits during the reporting period. *Timeframe decreased

12 Protect Electronic Health Information Measure: Conduct or review a security risk analysis in accordance with the requirements under 45 CFR (a)(1), including addressing the encryption/security of data at rest and implement security updates as necessary and correct identified security deficiencies as part of its risk management process. Exclusions: None *No change

13 Incorporate Clinical Lab-Test Results Measure: >55% of all clinical lab tests ordered by the EP during the reporting period whose results are either in a positive, negative, or numerical format are incorporated in CEHRT as structured data. Exclusion: EP does not order any lab tests during the reporting period or if none of the results from the tests ordered are a number or a positive/negative response. *Increased threshold, menu to core measure

14 Patient Reminders Measure: >10% of all unique patients who have had 2 office visits with the EP within the 24 months before the beginning of the reporting period were sent a reminder, per patient preference when available. Exclusion: EP has no office visits in the 24 months before the reporting period. *Threshold decreased, patient criteria changed, menu to core measure

15 Generate Lists of Patients Measure: Generate at least one report listing patients of the EP with a specific condition. Exclusion: None *Menu to core measure

16 Education Resources Measure: >10% of all unique patients with office visits are provided patient-specific education resources Exclusion: EP has no office visits during the reporting period *Menu to core measure

17 Medication Reconciliation Measure: The EP performs medication reconciliation for >50% of transitions of care in which the patient is transitions into the care of the EP. Exclusion: The EP did not see any patients after they received care from another provider. *Menu to core measure

18 Summary of Care Record Measure 1: Provide a summary of care record for >50% of transitions of care and referrals and Measure 2: Provide a summary of care record for >10% of the total number of transitions and referrals either (a) electronically transmitted using CEHRT to a recipient or (b) where the recipient receives the summary of care record via exchange facilitated by an organization that is an ehealth exchange participant or in a manner that is consistent with the governance mechanism ONC establishes for the ehealth Exchange. And EPs must also satisfy one of the following: Conduct 1 successful electronic exchanges or a summary of care document, as part of which is counted in measure 2 with a recipient who has EHR technology that was developed/designed by a different EHR developer than the sender s EHR. Conduct 1 successful tests with the CMS designated test EHR during the reporting period. Exclusion: EP transfers a patient to another setting or refers a patient to another provider <100 times during the reporting period. *Menu to core measure, 2 additional requirements

19 Immunization Registries Measure: Successful ongoing submission of electronic immunization data from CEHRT to an immunization registry or immunization information system for the entire reporting period. Exclusion: EP does not administer immunizations to any of the populations for which data is collected by their jurisdiction's immunization registry EP operates in a jurisdiction where no immunization registry is capable of accepting the specific standards required for their EHR EP operates in a jurisdiction where no immunization registry provides timely information on capability to receive immunization data EP operates in a jurisdiction for which no immunization registry that is capable of accepting the specific standards required by their EHR can enroll additional EPs *Menu to core measure

20 Secure Electronic Messaging Measure: A secure message was sent using the electronic messaging function of CEHRT by >5% of unique patients (or their authorized representatives) seen by the EP during the EHR reporting period. Exclusion: EP has no office visits during the reporting period or practices in an area with low broadband availability. *New measure

21 Menu Measures 1. Syndromic Surveillance Data 2. Electronic Notes 3. Imaging Results 4. Patient Family Health History 5. Central Cancer Registry 6. Specialized Registry *EPs must meet three Menu Measures

22 Syndromic Surveillance Data Measure: EP performs successful ongoing submission of electronic syndromic surveillance data from CEHRT to a public health agency for the entire reporting period. Exclusion: EP is not in a category of providers that collect ambulatory syndromic surveillance information on patients during the reporting period EP operates in a jurisdiction for which no public health agency is capable of receiving electronic syndromic surveillance data in the specific standards required by the EHR EP operates in a jurisdiction where no public health agency provides timely information on the capability to receive syndromic surveillance data EP operates in a jurisdiction for which no public health agency that is capable of accepting the specific standards required by the HER can enroll additional EPs

23 Record Electronic Notes Measure: Enter 1 electronic progress note created, edited and signed by an EP for >30% of unique patients with at least 1 office visit during the reporting period. Electronic progress notes must be text-searchable, drawings and other content can be included. Exclusion: None

24 Imaging Results Accessible Measure: >10% of all tests whose result is one or more images ordered by the EP during the reporting period are accessible through CEHRT. Images can be stored in the EHR or a direct link can be made available in the EHR that takes the viewer to the image test result. Exclusion: EP orders<100 tests that yield an image during the reporting period, or EP doesn t have access to electronic imaging results at the start of the reporting period.

25 Record Patient Family Health History Measure: More than 20% of all unique patients seen by the EP during the reporting period have a structured data entry for one or more first-degree relatives. Exclusion: EP has no office visits during the reporting period

26 Report Cancer Cases to Registry Measure: Successful ongoing submission of cancer case information from CEHRT to a public health central cancer registry for the entire reporting period. Exclusion: EP does not diagnose or directly treat cancer. EP operates in a jurisdiction for which no public health agency is capable of receiving electronic cancer case information in the specific standards required for the EHR EP operates in a jurisdiction where no public health agency for which they are eligible provides timely information on the capability to receive electronic cancer case information. EP operates in a jurisdiction for which no public health agency that is capable of receiving electronic cancer case information in the specific standards required for the EHR can enroll additional EPs.

27 Report Cases to Specialized Registries Measure: Successful ongoing submission of specific case information from CEHRT to a specialized registry for the entire reporting period. A specialized registry I usually associated with a specific disease and is sponsored or maintained by a national specialty society and/or a public health agency. Exclusion: EP does not diagnose or directly treat any disease associated with a specialized registry sponsored by a national specialty society or the public health agencies in their jurisdiction EP operates in a jurisdiction for which: No specialized registry sponsored by a public health agency or by a national specialty society for which you are eligible is capable of receiving electronic specific case information in the specific standards required by the EHR No public health agency or national specialty society for which you are eligible provides timely information on the capability to receive information into specialized registries. No specialized registry sponsored by a public health agency or by a national specialty society for which you are eligible is capable of receiving electronic specific case information in the specific standards required by the EHR can enroll additional EPs.

28 Clinical Quality Measures: Must report on 9 of 64 CQMs CQMs must cover at least 3 of the 6 available NQS domains: Patient and Family Engagement Patient Safety Care Coordination Population and Public Health Efficient Use of Health Care Resources Clinical Processes/Effectiveness

29 Modification to Meaningful Use NPRM

30 Polling Question #1 Please indicate the setting in which you provide health care: a) Primary Care Ambulatory b) Specialty Care Ambulatory c) Hospital d) Other

31 Proposed Timeline 90-day reporting period for all EPs in 2015 only 90-day reporting period for new participants in 2016 Full-year reporting period for returning participants in 2016 Full-year reporting period for returning and new participants in 2017 Exception for new Medicaid EPs only, may use 90-day reporting period Reporting period based on calendar year (not fiscal year) Continue to use 2014 Edition CEHRT (may upgrade to 2015 edition prior to 2018)

32 Changes to Requirements Eliminate distinction between core and menu objectives 9 required objectives based on Stage 2 objectives Special exclusions for EPs still in Stage 1 Removal of redundant, duplicative, or topped out measures No change to CQM requirements Measure Changes: Changing the threshold from the Stage 2 Objective for Patient Electronic Access measure number 2 from 5% to 1 patient Changing the threshold from the Stage 2 Objective Secure Electronic Messaging from being a percentage-based measure, to yes-no measure stating the functionality fully enabled Consolidating all public health reporting objectives into one objective with measure options

33 Removed Measures Record Demographics Record Vital Signs Record Smoking Status Clinical Summaries Structured Lab Results Patient Lists Patient Reminders Summary of Care Measure 1- Any Method Measure 3- Test Electronic Notes Imaging Results Family Health History

34 Objectives 1. CPOE 2. Electronic Prescribing 3. Clinical Decision Support 4. Patient Electronic Access 5. Protect Electronic Health Information 6. Patient Specific Education 7. Medication Reconciliation 8. Summary of Care 9. Secure Messaging 10.Public Health Reporting

35 Computerized Provider Order Entry Objective for Proposed Measures for Providers in Alternatives for Stage 1 Providers only in 2015 CPOE Measure 1: > 60% of medication orders created by the EP during the reporting period are recorded using CPOE. Measure 2: > 30% of laboratory orders created by the EP during the reporting period are recorded using CPOE Measure 3: > 30% of radiology orders created by the EP during the reporting period are recorded using CPOE. Measure 1: > 30% of all unique patients with at least 1 medication in their medication list seen by the EP during the reporting period have at least one medication order entered using CPOE; or > 30 % of medication orders created by the EP during the reporting period are recorded using CPOE. Provider may claim an exclusion Provider may claim an exclusion

36 Electronic Prescribing (erx) Objective for erx Proposed Measures for Providers in > 50% of all permissible prescriptions written by the EP are queried for a drug formulary and transmitted electronically using CEHRT. Alternatives for Stage 1 Providers only in 2015 > 40% of all permissible prescriptions written by the EP are transmitted electronically using CEHRT.

37 Clinical Decision Support (CDS) Objective for Clinical Decision Support Proposed Measures for Providers in Measure 1: Implement 5 clinical decision support interventions related to 4 or more CQMs at a relevant point in patient care for the entire reporting period. Absent 4 CQMs related to an EP's scope of practice or patient population, the clinical decision support interventions must be related to highpriority health conditions. It is suggested that one of the five clinical decision support interventions be related to improving healthcare efficiency. Measure 2: The EP has enabled and implemented the functionality for drug-drug and drug allergy interaction checks for the entire reporting period. Exclusion: EP who writes fewer than 100 medication orders during the reporting period. Alternatives for Stage 1 Providers only in 2015 Implement one clinical decision support rule relevant to specialty or high clinical priority along with the ability to track compliance with that rule. None

38 Patient Electronic Access Objective for Proposed Measures for Providers in Patient Electronic Access (VDT) Measure 1: > 50% of all unique patients seen by the EP during the reporting period are provided timely (within 4 business days after the information is available to the EP) online access to their health information subject to the EP's discretion to withhold certain information. Alternatives for Stage 1 Providers only in 2015 None Measure 2: At least one patient seen by the EP during the reporting period (or their authorized representatives) views, downloads, or transmits his or her health information to a third party. Provider may claim an exclusion

39 Protect Electronic Health Information Objective for Protect Electronic Health Information Proposed Measures for Providers in Conduct or review a security risk analysis in accordance with the requirements in 45 CFR (a)(1), including addressing the security (to include encryption) of ephi data stored in CEHRT in accordance with requirements in 45 CFR (a)(2)(iv) and 45 CFR (d)(3), and implement security updates as necessary and correct identified security deficiencies as part of the EP, EH, or CAHs risk management process. Alternatives for Stage 1 Providers only in 2015 None

40 Patient Specific Education Objective for Proposed Measures for Providers in Alternatives for Stage 1 Providers only in 2015 Patient Specific Education Patient-specific education resources identified by CEHRT are provided to patients for > 10% of all unique patients with office visits seen by the EP during the reporting period. Provider may claim an exclusion if they did not intend to select the Stage 1 Patient Specific Education menu objective.

41 Medication Reconciliation Objective for Proposed Measures for Providers in Alternatives for Stage 1 Providers only in 2015 Medication Reconciliation The EP performs medication reconciliation for >50% of transitions of care in which the patient is transitioned into the care of the EP. Provider may claim an exclusion if they did not intend to select the Stage 1 Medication Reconciliation menu objective.

42 Summary of Care Objective for Proposed Measures for Providers in Alternatives for Stage 1 Providers only in 2015 Summary of Care The EP that transitions or refers their patient to another setting of care or provider of care (1) uses CEHRT to create a summary of care record; and (2) electronically transmits such summary to a receiving provider for > 10% of transitions of care and referrals. Provider may claim an exclusion for Measure 2

43 Secure Messaging Objective for Proposed Measures for Providers in Alternatives for Stage 1 Providers only in 2015 Secure Messaging During the reporting period, the capability for patients to send and receive a secure electronic message with the provider was fully enabled. EP may claim an exclusion for the measure

44 Public Health Reporting Single objective with multiple measure options: Stage 2 EPs must report on 2 of the 5 options Stage 1 EPS may select 1 of the 5 options 1. Immunization Registry Reporting: The EP is in active engagement with a public health agency to submit immunization data and receive immunization forecasts and histories from the public health immunization registry/immunization information system (IIS). 2. Syndromic Surveillance Reporting: The EP is in active engagement with a public health agency to submit syndromic surveillance data from a non-urgent care ambulatory setting for EPs 3. Case Reporting: The EP is in active engagement with a public health agency to submit case reporting of reportable conditions. 4. Public Health Registry Reporting: The EP is in active engagement with a public health agency to submit data to public health registries. 5. Clinical Data Registry Reporting: The EP is in active engagement to submit data to a clinical data registry.

45 Attestation Changes 2015 attestation for Medicare EPs cannot be done prior to January 1, 2016 EPs eligible for both Medicare and Medicaid who do not meet Medicaid patient volume requirements can attest through CMS Registration and Attestation Avoids Medicare payment adjustment Not eligible for incentive payment

46 Polling Question #2 For those practices participating in the Meaningful Use Incentive Program, please indicate if you will be submitting PQRS directly from your EHR or a DSV, if you will be submitting PQRS measures through a different means, or if you will not be submitting PQRS measures for a) EHR Direct / Direct Submission Vendor (DSV) b) Other c) Not Participating

47 Stage 3 Meaningful Use: Proposed Rule Improved Outcomes

48 Program Changes Optional participation year in 2017 Beginning in 2018 all providers report on the same definition of MU (Stage 3) regardless of prior participation Medicare program participants must participate on a full year of reporting starting in 2017 regardless of stage 1st year Medicaid program participants can still use a 90-day reporting period All report on calendar year timeline rather than fiscal year timeline

49 CEHRT Requirements : Must use at a minimum 2014 Edition CEHRT May upgrade to the 2015 Edition CEHRT prior to 2018 Providers may use a combination of 2014 and 2015 Editions prior to 2018 if they have modules from both Editions which meet the requirements for the objectives or if they fully upgrade during a reporting period Must use 2015 Edition CEHRT by 2018 and in subsequent years

50 Participation Timeline

51 Objectives No longer core/menu measures, EPs must meet (or qualify for exclusions) for all 8 objectives and associated measures: 1. Protect Patient Health Information 2. Electronic Prescribing (erx) 3. Clinical Decision Support (CDS) 4. Computerized Provider Order Entry (CPOE) 5. Patient Electronic Access to Health Information 6. Coordination of Care through Patient Engagement 7. Health Information Exchange (HIE) 8. Public Health and Clinical Data Registry Reporting * Red italics indicate changes from Stage 2

52 Protect Patient Health Information Objective: Protect electronic protected health information (ephi) created or maintained by the certified EHR technology (CEHRT) through the implementation of appropriate technical, administrative, and physical safeguards Measure: Conduct or review a security risk analysis in accordance with the requirements under 45 CFR (a)(1), including addressing the security (to include encryption) of data stored in CEHRT in accordance with requirements under 45 CFR (a)(2)(iv) and 45 CFR (d)(3), implementing security updates as necessary, and correcting identified security deficiencies as part of the provider's risk management process Eps must conduct the security risk analysis upon installation of CEHRT or upon upgrade to a new edition of certified EHR Technology. The initial security risk analysis and testing may occur prior to the beginning of the first EHR reporting period using that certified EHR technology. In subsequent years, a provider must review the security risk analysis of the CEHRT and the administrative, physical, and technical safeguards implemented, and make updates to its analysis as necessary, but at least once per EHR reporting period. No exclusions *Addition of language to include administrative and physical safeguards, clarification of timing

53 Electronic Prescribing (erx) Objective: EPs generate and transmit permissible prescriptions electronically Measure: >80% of all permissible prescriptions written by the EP are queried for a drug formulary and transmitted electronically using CEHRT Exclusions: EPs who write <100 permissible prescriptions during the reporting period No pharmacies within a 10-mile radius of an EP s practice location at the start of the reporting period accept electronic prescriptions Denominator: Number of prescriptions written for drugs requiring a prescription in order to be dispensed other than controlled substances during the reporting period or number of prescriptions written for drugs requiring a prescription in order to be dispensed during the reporting period. Numerator: The number of prescriptions in the denominator generated, queried for a drug formulary, and transmitted electronically using CEHRT. *Increased threshold

54 Clinical Decision Support (CDS) Objective: Implement clinical decision support (CDS) interventions focused on improving performance on high-priority health conditions. Measure 1: Implement five clinical decision support interventions related to four or more CQMs at a relevant point in patient care for the entire EHR reporting period. Absent four CQMs related to an EP s scope of practice or patient population, the clinical decision support interventions must be related to high-priority health conditions. Measure 2: The EP has enabled and implemented the functionality for drug-drug and drugallergy interaction checks for the entire EHR reporting period. Exclusion: For Measure 2, any EP who writes <100 medication orders during the reporting period. *No change from Stage 2

55 *Inclusion of diagnostic imaging, increased thresholds Computerized Provider Order Entry (CPOE) Objective: Use computerized provider order entry for medication, laboratory, and diagnostic imaging orders directly entered by any licensed healthcare professional, credentialed medical assistant, or a medical staff member credentialed to and performing the equivalent duties of a credentialed medical assistant; who can enter orders into the medical record per state, local, and professional guidelines. Measure 1: > 80% of medication orders created by the EP during the reporting period are recorded using CPOE; Exclusion: Any EP who writes <100 medication orders during the EHR reporting period. Denominator: Number of medication orders created by the EP during the reporting period. Numerator: The number of orders in the denominator recorded using CPOE. Measure 2: > 60% of laboratory orders created by the EP during the reporting period are recorded using CPOE; Exclusion: Any EP who writes <100 laboratory orders during the EHR reporting period. Denominator: Number of laboratory orders created by the EP during the reporting period. Numerator: The number of orders in the denominator recorded using CPOE. Measure 3: > 60% of diagnostic imaging orders created by the EP during the reporting period are recorded using CPOE. Exclusion: Any EP who writes <100 diagnostic imaging orders during the reporting period. Denominator: Number of diagnostic imaging orders created by the EP during the reporting period. Numerator: The number of orders in the denominator recorded using CPOE.

56 Patient Electronic Access to Health Information Objective: The EP provides access for patients to view online, download, and transmit their health information, or retrieve their health information through an API, within 24 hours of its availability. Measure 1: > 80% of all unique patients seen by the EP: (1) The patient (or patient-authorized representative) is provided access to view online, download, and transmit their health information within 24 hours of its availability to the provider; or (2) The patient (or patient-authorized representative) is provided access to an ONC-certified API that can be used by third-party applications or devices to provide patients (or patientauthorized representatives) access to their health information, within 24 hours of its availability to the provider. Exclusions: - An EP who has no office visits during the reporting period. - Any EP that conducts 50% or more of his or her patient encounters in a county that does not have 50% or more of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the reporting period. Denominator: The number of unique patients seen by the EP during the reporting period. Numerator: The number of patients in the denominator who are provided access to information within 24 hours of its availability to the EP. *Combination of measures, addition of APIs, increased threshold, decreased patient wait time

57 Patient Electronic Access to Health Information (continued) Measure 2: Use clinically relevant information from CEHRT to identify patient-specific educational resources and provide electronic access to those materials to >35% of unique patients seen by the EP during the reporting period. Exclusions: An EP who has no office visits during the reporting period. Any EP that conducts 50% of his or her patient encounters in a county that does not have 50% of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the reporting period Denominator: The number of unique patients seen by the EP during the reporting period. Numerator: The number of patients in the denominator who were provided electronic access to patientspecific educational resources using clinically relevant information identified from CEHRT.

58 Coordination of Care through Patient Engagement Objective: Use communications functions of certified EHR technology to engage with patients or their authorized representatives about the patient's care. EPs must attest to the numerator and denominator for all 3 measures, but would only be required to successfully meet the threshold for 2 of the 3 proposed measures Measure 1: During the reporting period, > 25% of all unique patients seen by the EP actively engage with the EHR made accessible by the provider. EP may meet the measure by either: (1) >25 % of all unique patients (or patient-authorized representatives) seen by the EP during the reporting period view, download or transmit to a third party their health information; or (2) >25 % of all unique patients (or patient-authorized representatives) seen by the EP during the reporting period access their health information through the use of an ONC-certified API that can be used by third-party applications or devices. (1) Denominator: Number of unique patients seen by the EP during the reporting period. (1) Numerator: The number of unique patients (or their authorized representatives) in the denominator who have viewed online, downloaded, or transmitted to a third party the patient's health information; or (2) Denominator: The number of unique patients seen by the EP during the EHR reporting period. (2) Numerator: The number of unique patients (or their authorized representatives) in the denominator who have accessed their health information through the use of an ONC-certified API. *Combination of measures, increased thresholds

59 Coordination of Care through Patient Engagement (continued) Measure 2: >35% of all unique patients seen by the EP during the reporting period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient's authorized representatives), or in response to a secure message sent by the patient (or the patient's authorized representative). Denominator: Number of unique patients seen by the EP during the reporting period. Numerator: The number of patients in the denominator for whom a secure electronic message is sent to the patient, the patient's authorized representatives, or in response to a secure message sent by the patient. Measure 3: Patient-generated health data or data from a non-clinical setting is incorporated into the certified EHR technology for >15% of all unique patients seen by the EP during the reporting period. Denominator: Number of unique patients seen by the EP during the reporting period. Numerator: The number of patients in the denominator for whom data from non-clinical settings, which may include patient-generated health data, is captured through the CEHRT into the patient record. Exclusions: Applicable for any measure/option: EP who has no office visits during the reporting period EP that conducts 50% or more of his/her patient encounters in a county that does not have 50% or more of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the reporting period

60 Health Information Exchange (HIE) Objective: EP provides a summary of care record when transitioning or referring their patient to another setting of care, retrieves a summary of care record upon the first patient encounter with a new patient, and incorporates summary of care information from other providers into their EHR using the functions of certified EHR technology. Providers must attest to the numerator and denominator for all three measures, but would only be required to successfully meet the threshold for two of the three proposed measures Measure 1: > 50% of transitions of care and referrals, the EP that transitions or refers their patient to another setting of care or provider of care: (1) creates a summary of care record using CEHRT; and (2) electronically exchanges the summary of care record. Denominator: Number of transitions of care and referrals during the EHR reporting period for which the EP was the transferring or referring provider. Numerator: The number of transitions of care and referrals in the denominator where a summary of care record was created using certified EHR technology and exchanged electronically. Exclusion: An EP neither transfers a patient to another setting nor refers a patient to another provider during the reporting period. Measure 2: > 40% of transitions or referrals received and patient encounters in which the provider has never before encountered the patient, the EP incorporates into the patient's EHR an electronic summary of care document from a source other than the provider's EHR system. Denominator: Number of patient encounters during the reporting period for which an EP was the receiving party of a transition or referral or has never before encountered the patient and for which an electronic summary of care record is available. Numerator: Number of patient encounters in the denominator where an electronic summary of care record received is incorporated by the provider into the CEHRT Exclusion: Any EP for whom the total of transitions or referrals received and patient encounters in which the provider has never before encountered the patient, is <100 during the reporting period

61 Health Information Exchange (HIE) (continued) Measure 3: > 80% of transitions or referrals received and patient encounters in which the provider has never before encountered the patient, the EP performs a clinical information reconciliation. The provider must implement clinical information reconciliation for the following three clinical information sets: 1. Medication. Review of the patient's medication, including the name, dosage, frequency, and route of each medication. 2. Medication allergy. Review of the patient's known allergic medications. 3. Current Problem list. Review of the patient's current and active diagnoses. Denominator: Number of transitions of care or referrals during the reporting period for which the EP was the recipient of the transition or referral or has never before encountered the patient. Numerator: The number of transitions of care or referrals in the denominator where the following three clinical information reconciliations were performed: medication list, medication allergy list, and current problem list. Exclusion: Any EP for whom the total of transitions or referrals received and patient encounters in which the provider has never before encountered the patient, is <100 during the reporting period. Exclusions: Applicable for any of the three measures: EP that conducts 50% or more of his/her patient encounters in a county that does not have 50% or more of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the reporting period

62 Public Health and Clinical Data Registry Reporting Active Engagement Option 1 Completed Registration to Submit Data: The EP registered to submit data with the PHA or, where applicable, the CDR to which the information is being submitted; registration was completed within 60 days after the start of the EHR reporting period; and the EP is awaiting an invitation from the PHA or CDR to begin testing and validation. This option allows providers to meet the measure when the PHA or the CDR has limited resources to initiate the testing and validation process. Providers that have registered in previous years do not need to submit an additional registration to meet this requirement for each reporting period. Active Engagement Option 2 Testing and Validation: The EP is in the process of testing and validation of the electronic submission of data. Providers must respond to requests from the PHA or, where applicable, the CDR within 30 days; failure to respond twice within a reporting period would result in that provider not meeting the measure. Active Engagement Option 3 Production: The EP has completed testing and validation of the electronic submission and is electronically submitting production data to the PHA or CDR. * Adds flexibility options & consolidates measures

63 Public Health and Clinical Data Registry Reporting (continued) EPs would be required to choose from measures 1-5, and would be required to successfully attest to any combination of 3 measures. Measure 1 Immunization Registry Reporting: The EP is in active engagement with a public health agency to submit immunization data and receive immunization forecasts and histories from the public health immunization registry/immunization information system (IIS). Exclusions: EP: (1) Does not administer any immunizations to any of the populations for which data is collected by their jurisdiction's immunization registry or immunization information system during the reporting period; (2) operates in a jurisdiction for which no immunization registry or immunization information system is capable of accepting the specific standards required to meet the CEHRT definition at the start of the reporting period; or (3) operates in a jurisdiction where no immunization registry or immunization information system has declared readiness to receive immunization data at the start of the reporting period. Measure 2 Syndromic Surveillance Reporting: The EP is in active engagement with a public health agency to submit syndromic surveillance data from a non-urgent care ambulatory setting Exclusions: EP: (1) Does not treat or diagnose or directly treat any disease or condition associated with a syndromic surveillance system in their jurisdiction; (2) operates in a jurisdiction for which no public health agency is capable of receiving electronic syndromic surveillance data from EPs in the specific standards required to meet the CEHRT definition at the start of the reporting period; or (3) operates in a jurisdiction where no public health agency has declared readiness to receive syndromic surveillance data from EPs at the start of the reporting period.

64 Public Health and Clinical Data Registry Reporting (continued) Measure 3 Case Reporting: The EP is in active engagement with a public health agency to submit case reporting of reportable conditions. Exclusions: EP: (1) Does not treat or diagnose any reportable diseases for which data is collected by their jurisdiction's reportable disease system during the reporting period; (2) operates in a jurisdiction for which no public health agency is capable of receiving electronic case reporting data in the specific standards required to meet the CEHRT definition at the start of the reporting period; or (3) operates in a jurisdiction where no public health agency has declared readiness to receive electronic case reporting data at the start of the reporting period. Measure 4 Public Health Registry Reporting: The EP is in active engagement with a public health agency to submit data to public health registries. Exclusions: EP: (1) Does not diagnose or directly treat any disease or condition associated with a public health registry in their jurisdiction during the reporting period; (2) operates in a jurisdiction for which no public health agency is capable of accepting electronic registry transactions in the specific standards required to meet the CEHRT definition at the start of the reporting period; or (3) operates in a jurisdiction where no public health registry for which the EP is eligible has declared readiness to receive electronic registry transactions at the beginning of the reporting period. Measure 5 Clinical Data Registry Reporting: The EP is in active engagement to submit data to a clinical data registry. Exclusions: EP: (1) Does not diagnose or directly treat any disease or condition associated with a clinical data registry in their jurisdiction during the reporting period; (2) operates in a jurisdiction for which no clinical data registry is capable of accepting electronic registry transactions in the specific standards required to meet the CEHRT definition at the start of the reporting period; or (3) operates in a jurisdiction where no clinical data registry for which the EP is eligible has declared readiness to receive electronic registry transactions at the beginning of the reporting period.

65 Clinical Quality Measures (CQMs) Reporting requirements will be addressed for 2017 and subsequent years in the Medicare Physician Fee Schedule (PFS) rulemaking for EPs Goal is to further align and avoid redundant or duplicative reporting across various CMS quality reporting programs Reporting can be via electronic reporting (preferred) or attestation EHRs will gradually be required to support all CQMs

66 Q&A

Proposed Stage 3 Meaningful Use Criteria

Proposed Stage 3 Meaningful Use Criteria Centers for Medicare and Medicaid Services Proposed Stage 3 Meaningful Use Criteria Objectives and Measure Summary March 20, 2015 Provided by Clinical Architecture LLC Contents Overview... 3 Objective

More information

result, the core/menu structure would be removed and the total number of objectives reduced.

result, the core/menu structure would be removed and the total number of objectives reduced. On April 10, 2015, CMS released the proposed rule for Meaningful Use in 2015 through 2017. This document summarizes the key points from that proposal. - Reporting Period Length - 2015: 90 consecutive days

More information

EHR Incentive Program Stage 3 Objectives & Measures Crosswalk of Stage 3 Proposed Objectives, Measures & Corresponding Stage 2 Measures

EHR Incentive Program Stage 3 Objectives & Measures Crosswalk of Stage 3 Proposed Objectives, Measures & Corresponding Stage 2 Measures EHR Incentive Program Stage 3 Objectives & Measures Crosswalk of Stage 3 Proposed Objectives, Measures & Corresponding Stage 2 Measures Objective 1: Protect Patient Health Information Measures: 1 (Complete

More information

STAGE 2 MEANINGFUL USE CORE AND MENU MEASURES FOR ELIGIBLE PROFESSIONALS

STAGE 2 MEANINGFUL USE CORE AND MENU MEASURES FOR ELIGIBLE PROFESSIONALS STAGE 2 MEANINGFUL USE CORE AND MENU MEASURES FOR ELIGIBLE PROFESSIONALS CORE MEASURES must meet all CPOE for Medication, Laboratory and Radiology Orders Objective: Use computerized provider order entry

More information

Final Rule - Stage 3 Meaningful Use Criteria

Final Rule - Stage 3 Meaningful Use Criteria Centers for Medicare and Medicaid Services Final Rule - Stage 3 Meaningful Use Criteria Objectives and Measures Summary October 22, 2015 Version 1.2 Provided by www.clinicalarchitecture.com Contents Overview...

More information

Meaningful Use in 2015 and Beyond Changes for Stage 2

Meaningful Use in 2015 and Beyond Changes for Stage 2 Meaningful Use in 2015 and Beyond Changes for Stage 2 Jennifer Boaz Transformation Support Specialist Proprietary 1 Definitions AIU = Adopt, Implement or Upgrade EP = Eligible Professional API = Application

More information

EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview

EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview CMS recently released a final rule that specifies criteria that eligible professionals (EPs), eligible hospitals, and critical access

More information

EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2015 Tipsheet

EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2015 Tipsheet EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2015 Tipsheet CMS recently published a final rule that specifies criteria that eligible professionals (EPs), eligible hospitals,

More information

Modified Stage 2 Meaningful Use Measures 2015-2017

Modified Stage 2 Meaningful Use Measures 2015-2017 Modified Stage 2 Meaningful Use s 2015-2017 Objective 1: Protect Electronic Health Information NONE Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.308(a)(1)

More information

Stage Two Meaningful Use Measures for Eligible Professionals

Stage Two Meaningful Use Measures for Eligible Professionals Stage Two Meaningful Use Measures for Eligible Professionals GENERAL REQUIREMENT FOR ELIGIBLE PROFESSIONALS Objective Measure Numerator, Denominator, & Exclusion Application Tips Required by the Final

More information

Stage 3 Meaningful Use - Finalized Objectives and Measures. Objective Description Measures Exclusions

Stage 3 Meaningful Use - Finalized Objectives and Measures. Objective Description Measures Exclusions Objective # & Name 1-Protect Electronic Health Information 2-Electronic Prescribing (erx) Objective Description Measures Exclusions Protect electronic protected health information (ephi) created or maintained

More information

Medicaid EHR Incentive Program

Medicaid EHR Incentive Program Medicaid EHR Incentive Program Modified Stage 2: through 2017 November 10, Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com November 10, 1 Key Concepts for Modified Stage 2 Restructured

More information

APPENDIX A: OBJECTIVES AND MEASURES FOR 2015 THROUGH 2017 (MODIFIED STAGE 2) EP Objectives and Measures

APPENDIX A: OBJECTIVES AND MEASURES FOR 2015 THROUGH 2017 (MODIFIED STAGE 2) EP Objectives and Measures APPENDIX A: OBJECTIVES AND MEASURES FOR 2015 THROUGH (MODIFIED STAGE 2) Objectives for Measures for Providers in EP Objectives and Measures Objective 1: Protect Patient Health Information Objective 2:

More information

EHR Incentive Program Stage 2 Objectives Summary CORE OBJECTIVES (You must meet all objectives unless exclusion applies.)

EHR Incentive Program Stage 2 Objectives Summary CORE OBJECTIVES (You must meet all objectives unless exclusion applies.) EHR Incentive Program Stage 2 Objectives Summary CORE OBJECTIVES (You must meet all objectives unless exclusion applies.) TARGETING CANCER CARE Objective Objective Description Measure/Attestation Requirement

More information

STAGE 2 of the EHR Incentive Programs

STAGE 2 of the EHR Incentive Programs EHR Incentive Programs A program administered by the Centers for Medicare & Medicaid Services (CMS) Eligible Professional s Guide to STAGE 2 of the EHR Incentive Programs September 2013 TABLE OF CONTENTS...

More information

STAGES 1 AND 2 REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1

STAGES 1 AND 2 REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1 STAGES 1 AND 2 REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1 Requirement CPOE Use CPOE for medication orders directly entered by any licensed health care professional who can enter orders into the

More information

Stage 1 vs. Stage 2 Comparison for Eligible Professionals

Stage 1 vs. Stage 2 Comparison for Eligible Professionals Stage 1 vs. Comparison for Eligible Professionals CORE OBJECTIVES (17 Total) Stage 1 Objective Stage 1 Measure Objective Measure Use CPOE for Medication orders directly entered by any licensed healthcare

More information

Meaningful Use: Stage 3 Proposed Rule Chart

Meaningful Use: Stage 3 Proposed Rule Chart Meaningful Use: Stage 3 Rule Chart Objectives: Objective 1-Protect Patient Health Information: Protect electronic protected health information (ephi) created or maintained by the CEHRT through the implementation

More information

MEETING MEANINGFUL USE IN MICROMD -STAGE TWO- Presented by: Anna Mrvelj EMR Training Specialist

MEETING MEANINGFUL USE IN MICROMD -STAGE TWO- Presented by: Anna Mrvelj EMR Training Specialist MEETING MEANINGFUL USE IN MICROMD -STAGE TWO- Presented by: Anna Mrvelj EMR Training Specialist 1 Proposed Rule On April 15, 2015 CMS Issued a new proposal rule for the Medicare and Medicaid EHR Incentive

More information

Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals Last Updated: August, 2012

Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals Last Updated: August, 2012 Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals Last Updated: August, 2012 CORE OBJECTIVES (17 total) Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Use CPOE for medication

More information

Meaningful Use. Medicare and Medicaid EHR Incentive Programs

Meaningful Use. Medicare and Medicaid EHR Incentive Programs Meaningful Use Medicare and Medicaid Table of Contents What is Meaningful Use?... 1 Table 1: Patient Benefits... 2 What is an EP?... 4 How are Registration and Attestation Being Handled?... 5 What are

More information

Protect Patient Health Information

Protect Patient Health Information Protect Patient Health Information Protect electronic protected health information (ephi) created or maintained by the certified EHR technology through the implementation of appropriate technical, administrative

More information

Meaningful Use 2015 and beyond. Presented by: Anna Mrvelj EMR Training Specialist

Meaningful Use 2015 and beyond. Presented by: Anna Mrvelj EMR Training Specialist Meaningful Use 2015 and beyond Presented by: Anna Mrvelj EMR Training Specialist 1 Agenda A look at the CMS Website Finding your EMR version Certification Number Proposed Rule by the Centers for Medicare

More information

Stage 3 Meaningful Use

Stage 3 Meaningful Use Stage 3 Meaningful Use In October 2015, CMS released the Medicare and Medicaid Programs: Electronic Health Record Incentive Program Stage 3 and Modifications to Meaningful Use in 2015 through 2017 final

More information

Stage 2 Meaningful Use: Objectives, Measures, Numerators/Denominators, and Exclusions

Stage 2 Meaningful Use: Objectives, Measures, Numerators/Denominators, and Exclusions 1 EP EH CPOE: Use CPOE for medication, laboratory and radiology orders directly entered by any licensed healthcare professional who can enter orders into the medical record per State, local and professional

More information

Reporting Period: For Stage 2, the reporting period must be the entire Federal Fiscal Year.

Reporting Period: For Stage 2, the reporting period must be the entire Federal Fiscal Year. Eligible Hospital and Critical Access Hospital (CAH) Attestation Worksheet for Stage 2 of the Medicare Electronic Health Record (EHR) Incentive Program The Eligible Hospital and CAH Attestation Worksheet

More information

Looking Ahead to 2016 and MU Audit Recommendations. Presented by: Gloria Carbonell February 10, 2016

Looking Ahead to 2016 and MU Audit Recommendations. Presented by: Gloria Carbonell February 10, 2016 Looking Ahead to 2016 and MU Audit Recommendations Presented by: Gloria Carbonell February 10, 2016 End of Meaningful Use The Meaningful Use program as it has existed, will now be effectively over and

More information

MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY STAGE 2 REQUIREMENTS EPs must meet or qualify for an exclusion to 17 core objectives EPs must meet 3 of the 6 menu measures.

More information

Summary of the Final Rule for Meaningful Use for 2015 and 2016. Meaningful Use Objectives for 2015 and 2016

Summary of the Final Rule for Meaningful Use for 2015 and 2016. Meaningful Use Objectives for 2015 and 2016 Image Research, LLC Christopher B. Sullivan, Ph.D. 2901 Quail Rise Court, Tallahassee, FL 32309 Summary of the Final Rule for Meaningful Use for 2015 and 2016 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers

More information

Modified Stage 2 Meaningful Use 2015-2017

Modified Stage 2 Meaningful Use 2015-2017 Click to edit Master title style Modified Stage 2 Meaningful Use 2015-2017 Bruce Maki, MA M-CEITA / Altarum Institute Regulatory & Incentive Program Analyst 12/14/2015 1 1 Agenda 1. Overview of M-CEITA

More information

Meaningful Use Stage 3 Proposed Rule: What it Means for Hospitals, Physicians & Health IT Developers

Meaningful Use Stage 3 Proposed Rule: What it Means for Hospitals, Physicians & Health IT Developers Meaningful Use Stage 3 Rule: What it Means for Hospitals, Physicians & Health IT Developers Vernessa T. Pollard and Nicole Liffrig Molife April 2015 With the publication of the Stage 3 Meaningful Use Rule

More information

Modified Stage Two Meaningful Use with Final Rule Quick Reference Guide

Modified Stage Two Meaningful Use with Final Rule Quick Reference Guide Modified Stage Two Meaningful Use 2015-2017 with Final Rule Quick Reference Guide To qualify for Stage 1 or 2, a provider must meet: 10 objectives, Including 2 consolidated public health measures Reporting

More information

Meaningful Use - Modified Stage through Alternate Exclusions and/or Specifications

Meaningful Use - Modified Stage through Alternate Exclusions and/or Specifications Objectives Measures for EPs in 2015 through 2017 Objective 1: Protect Patient Health Information Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.308(a)(1),

More information

Medicaid EHR Incentive Program. Focus on Stage 2. Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com

Medicaid EHR Incentive Program. Focus on Stage 2. Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com Medicaid EHR Incentive Program Focus on Stage 2 Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com Understanding Participation Program Year Program Year January 1 st - December 31st. Year

More information

STAGE 2 MEANINGFUL USE FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS (CAHS)

STAGE 2 MEANINGFUL USE FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS (CAHS) STAGE 2 MEANINGFUL USE FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS (CAHS) CORE MEASURES must meet all CPOE for Medication, Laboratory and Radiology Orders Objective: Use computerized provider

More information

Agenda. What is Meaningful Use? Stage 2 - Meaningful Use Core Set. Stage 2 - Menu Set. Clinical Quality Measures (CQM) Clinical Considerations

Agenda. What is Meaningful Use? Stage 2 - Meaningful Use Core Set. Stage 2 - Menu Set. Clinical Quality Measures (CQM) Clinical Considerations AQAF Health Information Technology Forum Meaningful Use Stage 2 Clinical Considerations Marla Clinkscales & Mike Bice Alabama Regional Extension Center (ALREC) August 13, 2013 0 Agenda What is Meaningful

More information

Medicaid EHR Incentive Program Dentists as Eligible Professionals. Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.

Medicaid EHR Incentive Program Dentists as Eligible Professionals. Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida. Medicaid EHR Incentive Program Dentists as Eligible Professionals Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com Considerations Must begin participation by Program Year 2016 Not required

More information

MEDICFUSION / HERFERT. MEANINGFUL USE STAGE 1 and 2 ATTESTATION GUIDE 2015

MEDICFUSION / HERFERT. MEANINGFUL USE STAGE 1 and 2 ATTESTATION GUIDE 2015 MEDICFUSION / HERFERT MEANINGFUL USE STAGE 1 and 2 ATTESTATION GUIDE 2015 The following document is intended to aid in preparation for gathering necessary information to attest in early 2016. All Medicfusion

More information

Meaningful Use Modification Rules for 2015-2017 Oct. 26, 2015 Author: Jennifer Swinnich, Associate Director, PAMED Practice Support

Meaningful Use Modification Rules for 2015-2017 Oct. 26, 2015 Author: Jennifer Swinnich, Associate Director, PAMED Practice Support Meaningful Use Modification Rules for 2015-2017 Oct. 26, 2015 Author: Jennifer Swinnich, Associate Director, PAMED Practice Support The following is a summary of the Meaningful Use Modifications for 2015-2017.

More information

Meaningful Use Updates. HIT Summit September 19, 2015

Meaningful Use Updates. HIT Summit September 19, 2015 Meaningful Use Updates HIT Summit September 19, 2015 Meaningful Use Updates Nadine Owen, BS,CHTS-IS, CHTS-IM Health IT Analyst Hawaii Health Information Exchange No other relevant financial disclosures.

More information

Modified Stage 2 Final Rule 2015-2017

Modified Stage 2 Final Rule 2015-2017 Modified Stage 2 Final Rule 2015-2017 Illinois Health Information Technology Regional Extension Center (ILHITREC) SUPPORT PROVIDED BY ILHITREC: The Illinois Health Information Technology Regional Extension

More information

Meaningful Use. Stage 1

Meaningful Use. Stage 1 Meaningful Use Stage 1 Core Objectives Must Meet all 13 Objectives 1. CPOE for Medication Orders 2. Drug Interaction Checks 3. Up-To-Date Problem List 4. E-Prescribing (erx) 5. Active Medication List 6.

More information

Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs Last Updated: August, 2012

Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs Last Updated: August, 2012 CORE OBJECTIVES (16 total) Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs Last Updated: August, 2012 Stage 1 Objective Use CPOE for medication orders directly entered by any licensed

More information

Meaningful Use Stage 2

Meaningful Use Stage 2 Meaningful Use Stage 2 Presented by: Sarah Leake, HTS Consultant HTS, a division of Mountain Pacific Quality Health Foundation 1 HTS Who We Are Stage 2 MU Overview Learning Objectives 2014 CEHRT Certification

More information

Meaningful Use Objectives

Meaningful Use Objectives Meaningful Use Objectives The purpose of the electronic health records (EHR) incentive program is not so much the adoption of health information technology (HIT), but rather how HIT can further the goals

More information

Eligible Professional s Checklist 2015 Modified Stage 2 Meaningful Use

Eligible Professional s Checklist 2015 Modified Stage 2 Meaningful Use This checklist provides a look into Ohio s Medicaid Provider Incentive Program (MPIP) system for eligible professionals and may be used as a guide to help eligible professionals gather information that

More information

MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY On August 24, the Centers for Medicare & Medicaid Services (CMS) posted the much anticipated final rule for Stage

More information

Meaningful Use Final Rule Update. Patti Kritzberger, RHIT, CHPS Tracey Regimbal, RHIT HIT-Quality Improvement Specialists

Meaningful Use Final Rule Update. Patti Kritzberger, RHIT, CHPS Tracey Regimbal, RHIT HIT-Quality Improvement Specialists Meaningful Use Final Rule Update Patti Kritzberger, RHIT, CHPS Tracey Regimbal, RHIT HIT-Quality Improvement Specialists Learning Objectives Gain understanding of Modified Stage 2 2015-2017 program requirements

More information

Meaningful Use: It s Not Too Late For 2015!

Meaningful Use: It s Not Too Late For 2015! Meaningful Use: It s Not Too Late For 2015! Jeffrey D. Lehrman, DPM, FACFAS, FASPS, FAPWH APMA Coding Committee Expert Panelist, Codingline.com Fellow, American Academy of Podiatric Practice Management

More information

Presented by. Terri Gonzalez Director of Practice Improvement North Carolina Medical Society

Presented by. Terri Gonzalez Director of Practice Improvement North Carolina Medical Society Presented by Terri Gonzalez Director of Practice Improvement North Carolina Medical Society Meaningful Use is using certified EHR technology to: Improve quality, safety, efficiency, and reduce errors Engage

More information

MEDICAL ASSISTANCE STAGE 2 SUMMARY

MEDICAL ASSISTANCE STAGE 2 SUMMARY MEDICAL ASSISTANCE STAGE 2 SUMMARY OVERVIEW On September 4, 2012, CMS published a final rule that specifies the Stage 2 Meaningful Use criteria that eligible professionals (EPs), eligible hospitals (EHs)

More information

Meaningful Use Criteria for Eligible Hospitals and Eligible Professionals (EPs)

Meaningful Use Criteria for Eligible Hospitals and Eligible Professionals (EPs) Meaningful Use Criteria for Eligible and Eligible Professionals (EPs) Under the Electronic Health Record (EHR) meaningful use final rules established by the Centers for Medicare and Medicaid Services (CMS),

More information

Stage 2 of Meaningful Use Summary of Proposed Rule

Stage 2 of Meaningful Use Summary of Proposed Rule Stage 2 of Meaningful Use Summary of Proposed Rule Background In order to receive incentives for the adoption of electronic health records (EHRs) under either the Medicare or Medicaid (Medi-Cal) incentive

More information

Meaningful Use Stage 2 Administrator Training

Meaningful Use Stage 2 Administrator Training Meaningful Use Stage 2 Administrator Training 1 During the call please mute your line to reduce background noise. 2 Agenda Review of the EHR Incentive Programs for Stage 2 Meaningful Use Measures and Corresponding

More information

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014 DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014 The chart below lists the measures (and specialty exclusions) that eligible providers must

More information

TABLE B5: STAGE 2 OBJECTIVES AND MEASURES

TABLE B5: STAGE 2 OBJECTIVES AND MEASURES 294 TABLE B5: STAGE 2 OBJECTIVES AND MEASURES CORE SET Improving quality, safety, efficiency, and reducing health disparities Use computerized provider order entry (CPOE) for medication, laboratory and

More information

Meaningful Use Finalized Objectives & Measures

Meaningful Use Finalized Objectives & Measures Objective # & Name Objective Description Measures Exclusions 1-Protect Patient None Health Information 2-Clinical Decision Support 3-Computerized Provider Order Entry (CPOE) Protect electronic health information

More information

TABLE 4: STAGE 2 MEANINGFUL USE OBJECTIVES AND ASSOCIATED MEASURES SORTED BY CORE AND MENU SET

TABLE 4: STAGE 2 MEANINGFUL USE OBJECTIVES AND ASSOCIATED MEASURES SORTED BY CORE AND MENU SET CMS-0044-P 156 TABLE 4: STAGE 2 MEANINGFUL USE OBJECTIVES AND ASSOCIATED MEASURES SORTED BY CORE AND MENU SET Improving quality, safety, efficiency, and reducing health disparities Use computerized provider

More information

Eligible Professionals (EPs) Purdue Research Foundation

Eligible Professionals (EPs) Purdue Research Foundation Understanding STAGE 2 Meaningful Use and the Incentive Program Eligible Professionals (EPs) About Incentives Eligible Professionals report during a calendar year Eligible Professionals can only attest

More information

Summary of Key Provisions: CMS EHR Incentive Program Modifications to Meaningful Use in 2015 through 2017 (Final Rule)

Summary of Key Provisions: CMS EHR Incentive Program Modifications to Meaningful Use in 2015 through 2017 (Final Rule) Summary of Key Provisions: CMS EHR Incentive Program Modifications to Meaningful Use in 2015 through 2017 (Final Rule) Structure of the Rules: CMS originally published three separate Proposed Rules: Health

More information

EHR Incentive Program Updates. Jason Felts, MS HIT Practice Advisor

EHR Incentive Program Updates. Jason Felts, MS HIT Practice Advisor EHR Incentive Program Updates Jason Felts, MS HIT Practice Advisor An Important Reminder For audio, you must use your phone: Step 1: Call (866) 906-0123. Step 2: Enter code 2071585#. Step 3: Mute your

More information

Meaningful Use Stage 2 MU Audits

Meaningful Use Stage 2 MU Audits Meaningful Use Stage 2 MU Audits Presented by: Deb Anderson, CPHIMS HTS Consultant HTS, a division of Mountain Pacific Quality Health Foundation 1 CEHRT Certified Electronic Health Record Technology (EHR)

More information

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015 DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015 The chart below lists the measures (and specialty exclusions) that eligible providers must

More information

Practice Partner Product Mappings to the ARRA/HITECH Stage 1 Meaningful Use Requirements for Eligible Providers

Practice Partner Product Mappings to the ARRA/HITECH Stage 1 Meaningful Use Requirements for Eligible Providers Product Mappings to the ARRA/HITECH Stage 1 Requirements for Eligible Providers Number CORE SET (These objectives are to be achieved by all eligible professionals in order to qualify for incentive payments.)

More information

Stage 2 Meaningful Use What the Future Holds. Lindsey Wiley, MHA HIT Manager Oklahoma Foundation for Medical Quality

Stage 2 Meaningful Use What the Future Holds. Lindsey Wiley, MHA HIT Manager Oklahoma Foundation for Medical Quality Stage 2 Meaningful Use What the Future Holds Lindsey Wiley, MHA HIT Manager Oklahoma Foundation for Medical Quality An Important Reminder For audio, you must use your phone: Step 1: Call (866) 906-0123.

More information

Stage 2 Final Rule Overview: Updates to Stage 1 and New Stage 2 Requirements

Stage 2 Final Rule Overview: Updates to Stage 1 and New Stage 2 Requirements Stage 2 Final Rule Overview: Updates to Stage 1 and New Stage 2 Requirements The Centers for Medicare and Medicaid Services (CMS) issued the Stage 2 Final Rule on September 4, 2012. The Stage 2 Final Rule

More information

Meaningful Use Stage 2: Summary of Proposed Rule for Eligible Professionals (EPs) Wyatt Packer HIT Regional Extension Center (REC) HealthInsight

Meaningful Use Stage 2: Summary of Proposed Rule for Eligible Professionals (EPs) Wyatt Packer HIT Regional Extension Center (REC) HealthInsight Meaningful Use Stage 2: Summary of Proposed Rule for Eligible Professionals (EPs) Wyatt Packer HIT Regional Extension Center (REC) HealthInsight Notice of Proposed Rule Making (NPRM) Stage 2 proposed rule

More information

Making Sense of Meaningful Use: Stage 2. Purdue Research Foundation

Making Sense of Meaningful Use: Stage 2. Purdue Research Foundation Making Sense of Meaningful Use: Stage 2 1 Who are we? Purdue Healthcare Advisors (PHA)*, a business unit of Purdue University, specializes in affordable assistance to organizations that share our passion

More information

CMS EHR Incentive Programs:

CMS EHR Incentive Programs: CMS EHR Incentive Programs: An Overview Meaningful Use Stages Vidya Sellappan Centers for Medicare & Medicaid Services Office of E-Health Standards and Services HIT Initiatives Group August 13, 2014 Table

More information

Meaningful Use Madness: Stage 3 Overview APRIL 08, 2015

Meaningful Use Madness: Stage 3 Overview APRIL 08, 2015 Meaningful Use Madness: Stage 3 Overview APRIL 08, 2015 Agenda Health IT Updates EHR Meaningful Use Incentive Program Rulemaking CMS Policy NPRM Stage 3 ONC Technical NPRM 2015 Edition CEHRT Proposed structural

More information

CMS Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs Final Rule Overview October 8, 2015

CMS Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs Final Rule Overview October 8, 2015 CMS Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs Final Rule Overview October 8, 2015 Elizabeth S. Holland Center for Clinical Standards and Quality Centers for Medicare & Medicaid

More information

Meaningful Use Overview (State of Affairs)

Meaningful Use Overview (State of Affairs) 2015 User Conference Meaningful Use Overview (State of Affairs) April 23, 2015 Presented by: Peter Minio Product Manager, Pediatric and Primary Care Solutions Co-Presenter: Cindy Malek Training Specialist

More information

EHR Incentive Program Focus on Stage One Meaningful Use. Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com October 16, 2014

EHR Incentive Program Focus on Stage One Meaningful Use. Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com October 16, 2014 EHR Incentive Program Focus on Stage One Meaningful Use Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com October 16, 2014 Checklist Participation Explanation Program Updates Stage One

More information

Webinar #1 Meaningful Use: Stage 1 & 2 Comparison CPS 12 & UDS 2013

Webinar #1 Meaningful Use: Stage 1 & 2 Comparison CPS 12 & UDS 2013 New York State-Health Centered Controlled Network (NYS HCCN) Webinar #1 Meaningful Use: Stage 1 & 2 Comparison CPS 12 & UDS 2013 January 31, 2014 Ekem Merchant-Bleiberg, Director of Implementation Services

More information

MEANINGFUL USE STAGE 2 Summary of Proposed Rule (EP)

MEANINGFUL USE STAGE 2 Summary of Proposed Rule (EP) MEANINGFUL USE STAGE 2 Summary of Proposed Rule (EP) The Meaningful Use Stage 2 Notice of Proposed Rule Making (NPRM) has been released and entered a 60-day comment period (March 7-May 6, 2012). HealthInsight

More information

Who are we? *Founded in 2005 by Purdue University, the Regenstrief Center for Healthcare Engineering, and the Indiana Hospital Association.

Who are we? *Founded in 2005 by Purdue University, the Regenstrief Center for Healthcare Engineering, and the Indiana Hospital Association. Who are we? Purdue Healthcare Advisors (PHA)*, a business unit of Purdue University, specializes in affordable assistance to organizations that share our passion for healthcare transformation. We bring

More information

Overview of the EHR Incentive Program

Overview of the EHR Incentive Program Overview of the EHR Incentive Program presented by Meaningful Use Stages 1 & 2 1 P Automated coding P Chief-complaint-driven P AnticiPlate Technology P Point-and-Click Functionality P erx through Surescripts

More information

The Future of Meaningful Use

The Future of Meaningful Use The Future of Meaningful Use Stage 3 Erin Dormaier, CHTS-IM, PCMH CCE Transformation Support Services Manager 2015 CORHIO All Rights Reserved CORHIO Proprietary Not For Redistribution 1 Agenda Stage 3

More information

Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method

Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method Use Computerized Provider Order Entry (CPOE) for medication orders directly entered by

More information

Understanding Meaningful Use Stage 2

Understanding Meaningful Use Stage 2 Understanding Meaningful Use Stage 2 Miranda Ladue, Manager, Product Management Adam Plotts, Manager, Product Management Copyright 2011 Allscripts Healthcare Solutions, Inc. Agenda Review MU Timeline MU

More information

Ophthalmology Meaningful Use Attestation Guide Stage 2 2014 Edition

Ophthalmology Meaningful Use Attestation Guide Stage 2 2014 Edition Ophthalmology Meaningful Use Attestation Guide Stage 2 2014 Edition Physicians who first participated in meaningful use in 2011 or 2012 must move on to Stage 2 in 2014. For 2014 only, physicians will attest

More information

EHR/Meaningful Use 2015-2017

EHR/Meaningful Use 2015-2017 EHR/Meaningful Use 2015-2017 The requirements for Meaningful Use attestation have changed due to the recently released Medicare and Medicaid Programs: Electronic Health Record Incentive Program Stage 3

More information

Meaningful Use 2015: Modified Stage 2 Objectives and Measures

Meaningful Use 2015: Modified Stage 2 Objectives and Measures Meaningful Use 2015: Modified Stage 2 Objectives and Measures Table of Contents Meaningful Use 2015:... 1 Modified Stage 2 Objectives and Measures... 1 Introduction to Stage 2 in 2015 CEHRT... 3 Stage

More information

Stage 1 Meaningful Use - Attestation Worksheet: Core Measures

Stage 1 Meaningful Use - Attestation Worksheet: Core Measures Stage 1 Meaningful Use - Attestation Worksheet: Core Measures Core Measures Objective # Objective Title / Explanation Goal Attestation Response - Values below reflect reponses of most radiologists Explanation

More information

Overview and Key Takeaways from the Proposed Rule on Meaningful Use Stage 3

Overview and Key Takeaways from the Proposed Rule on Meaningful Use Stage 3 Overview and Key Takeaways from the Proposed Rule on Meaningful Use Stage 3 April 2015 Impact Advisors LLC 400 E. Diehl Road Suite 190 Naperville IL 60563 1-800- 680-7570 Impact- Advisors.com Background

More information

Meaningful Use Stage 1:

Meaningful Use Stage 1: Whitepaper Meaningful Use Stage 1: EHR Incentive Program Information -------------------------------------------------------------- Daw Systems, Inc. UPDATED: November 2012 This document is designed to

More information

Three Proposed Rules on EHRs:

Three Proposed Rules on EHRs: Three Proposed Rules on EHRs: CMS 2015-2017 Modifications CMS Meaningful Use Stage 3 ONC s 2015 Edition Health IT (CEHRT) Lori Mihalich-Levin lmlevin@aamc.org Mary Wheatley mwheatley@aamc.org Ivy Baer

More information

9/9/2015. Medicare/Medicaid Incentive Program. Medicare/Medicaid Incentive Program. Meaningful Use, Penalties and Audits

9/9/2015. Medicare/Medicaid Incentive Program. Medicare/Medicaid Incentive Program. Meaningful Use, Penalties and Audits Meaningful Use, Penalties and Audits SHERI SMITH, FACMPE STATE VOLUNTEER MUTUAL INSURANCE COMPANY Copyright 2014 State Volunteer Mutual Insurance Company Medicare/Medicaid Incentive Program Medicare/Medicaid

More information

Incentives to Accelerate EHR Adoption

Incentives to Accelerate EHR Adoption Incentives to Accelerate EHR Adoption The passage of the American Recovery and Reinvestment Act (ARRA) of 2009 provides incentives for eligible professionals (EPs) to adopt and use electronic health records

More information

2015 Modified Stage 2 Requirements

2015 Modified Stage 2 Requirements 2015 Modified Stage 2 Requirements Your Guide To Being A Meaningful CEHRT User In 2015 Property of Advanced Provider Solutions, LLC. All rights reserved. Executive Summary The Medicare and Medicaid EHR

More information

Meaningful Use: Stage 1 and 2 Hospitals (EH) and Providers (EP) Lindsey Mongold, MHA HIT Practice Advisor Oklahoma Foundation for Medical Quality

Meaningful Use: Stage 1 and 2 Hospitals (EH) and Providers (EP) Lindsey Mongold, MHA HIT Practice Advisor Oklahoma Foundation for Medical Quality Meaningful Use: Stage 1 and 2 Hospitals (EH) and Providers (EP) Lindsey Mongold, MHA HIT Practice Advisor Oklahoma Foundation for Medical Quality Meaningful Use Stage 1 Focuses on Functional & Interoperability

More information

Appendix 2. PCMH 2014 and CMS Stage 2 Meaningful Use Requirements

Appendix 2. PCMH 2014 and CMS Stage 2 Meaningful Use Requirements Appendix 2 PCMH 2014 and CMS Stage 2 Meaningful Use Requirements Appendix 2 PCMH 2014 and CMS Stage 2 Meaningful Use Requirements 2-1 APPENDIX 2 PCMH 2014 AND CMS STAGE 2 MEANINGFUL USE REQUIREMENTS Medicare

More information

Meaningful Use 2014: Stage 2 MU Overview. Scott A. Jens, OD, FAAO October 16, 2013

Meaningful Use 2014: Stage 2 MU Overview. Scott A. Jens, OD, FAAO October 16, 2013 Meaningful Use 2014: Stage 2 MU Overview Scott A. Jens, OD, FAAO October 16, 2013 Overview General Overview of Stage 2 MU in 2014 Core Objectives for Stage 2 Menu Objectives for Stage 2 Complete summary

More information

Stage 2 Overview Tipsheet Last Updated: August, 2012

Stage 2 Overview Tipsheet Last Updated: August, 2012 Stage 2 Overview Tipsheet Last Updated: August, 2012 Overview CMS recently published a final rule that specifies the Stage 2 criteria that eligible professionals (EPs), eligible hospitals, and critical

More information

Stage 2 Meaningful Use

Stage 2 Meaningful Use Stage 2 Meaningful Use Stage 2 Topics Overview 2014 Reporting Changes Medicaid Provider Eligibility Measures Overview Core Objectives Comparison Menu Objectives Comparison Clinical Quality Measures 2 High

More information

Medicare & Medicaid EHR Incentive Programs

Medicare & Medicaid EHR Incentive Programs Medicare & Medicaid EHR Incentive Programs Eligibility 2 Who is Eligible to Participate? Eligibility was defined in statute Hospital-based EPs are NOT eligible for incentives DEFINITION: 90% or more of

More information

MICROMD EMR VERSION 9.0 2014 OBJECTIVE MEASURE CALCULATIONS

MICROMD EMR VERSION 9.0 2014 OBJECTIVE MEASURE CALCULATIONS MICROMD EMR VERSION 9.0 2014 OBJECTIVE MEASURE CALCULATIONS TABLE OF CONTENTS PREFACE Welcome to MicroMD EMR... i How This Guide is Organized... i Understanding Typographical Conventions... i Cross-References...

More information

Contact Information: West Texas Health Information Technology Regional Extension Center 3601 4 th Street MS 6232 Lubbock, Texas 79424 806-743-1338

Contact Information: West Texas Health Information Technology Regional Extension Center 3601 4 th Street MS 6232 Lubbock, Texas 79424 806-743-1338 Contact Information: West Texas Health Information Technology Regional Extension Center 3601 4 th Street MS 6232 Lubbock, Texas 79424 806-743-1338 http://www.wtxhitrec.org/ Grant award - $6.6m Total number

More information

MDeverywhere, Inc. Presents 2014 CMS EHR Incentive Program Requirements: What Providers Need To Know

MDeverywhere, Inc. Presents 2014 CMS EHR Incentive Program Requirements: What Providers Need To Know MDeverywhere, Inc. Presents 2014 CMS EHR Incentive Program Requirements: What Providers Need To Know Presented by: Kristen Heffernan Director Product Management & Marketing, Henry Schein MicroMD Agenda

More information

Attachment 1 Stage 1 Meaningful Use Criteria

Attachment 1 Stage 1 Meaningful Use Criteria Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method Use Computerized Provider Order Entry (CPOE) for medication orders directly entered by

More information